CD20-specific monoclonal antibodies administered to apoE−/− and LDLr−/− mice were shown to significantly decrease atherosclerosis, probably through reduction of the IgG type anti-oxLDL antibodies and through reduction in the accumulation of B-cells, macrophage, and T-lymphocytes in atherosclerotic plaques (180). Here, APOE is linked to atherosclerosis.